Cesar Trigueros is Chief Scientific Officer at Viralgen, where he specializes in Adeno-Associated Virus production for gene therapy manufacturing. His research interests include viral vector optimization and gene editing technologies, as well as enhancing manufacturing processes for therapeutic applications. Trigueros is dedicated to advancing the field of gene therapy by developing efficient production methods and exploring novel applications, ultimately striving to make significant contributions to the treatment of genetic disorders and improving therapeutic strategies for patients.